Pluto Biosciences, Inc

GSE154086: Expression profiling in cohesin mutant MCF10A epithelial and CMK leukaemia cells

Bulk RNA sequencing

MCF10A cells were CRISPR-Cas9 edited to create heterozygous deletion in RAD21 and SMC3 subunits of cohesin. STAG2 is on the X chromosome, hence CRISPR-Cas9 editing resulted in complete loss of STAG2. Total RNA was sequenced from the MCF10A parental and cohesin mutant MCF10A lines. The acute megakaryoblastic leukaemia cell line CMK was CRISPR-Cas9 edited to cotain STAG2 R614* mutation. CRISPR-Cas9 edited STAG2 mutant line showed complete loss of STAG2. CMK parental and the STAG2 mutant line were treated with Wnt3a for 4 hours and total RNA was sequenced at in the control or non-treated (con) and following 4 hours of Wnt3a treatment (Wnt3a4hr). SOURCE: Jisha Antony (jisha.antony@otago.ac.nz) - Horsfield University of Otago

View this experiment on Pluto Biosciences, Inc